TipRanks
Go Ultimate55% OFF

Global Health Clinics (MJRX.X) AI Stock Analysis

TSE:MJRX.X

Global Health Clinics

(CNQX:MJRX.X)

Select Model
Rating:43Neutral
Price Target:CAD 0.04â–Ľ(-90.25% Downside)
Action:reiterated
Date:08/24/26

The score is driven primarily by very weak financial performance (shrinking revenue, negative gross profit, persistent losses, negative equity and rising debt, and ongoing cash burn). Technical indicators also lean bearish with negative MACD and price below key moving averages, while valuation offers limited support due to negative earnings and no dividend yield.

Positive Factors
Losses Have ModeratedLower losses than in 2021 may indicate some reduction in the scale of deterioration. However, this is only a relative improvement because revenue is shrinking, gross profit remains negative, and the company is still materially unprofitable.
Negative Factors
Shrinking RevenuePersistent revenue contraction signals weakening demand, distribution, or product traction and reduces the scale available to absorb fixed costs. Continued declines would make a return to sustainable profitability more difficult over the next several months.

Global Health Clinics (MJRX.X) vs. iShares MSCI Canada ETF (EWC)

-100%-75%-50%-25%0%25%50%75%TSE:MJRX.X-11.11%EWC+21.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
CAD 417.43K
Dividend Yield
―
Average Volume (3M)
1,783
Price to Earnings (P/E)
-0.3
Beta (1Y)
-0.80
Revenue Growth
-78.90%
EPS Growth
-9.28%
Country
Canada
Employees
8
Sector
Healthcare
Sector Strength
51
Industry
Drug Manufacturers - Specialty & Generic

Global Health Clinics Business Overview & Revenue Model

Company Description

Operating within the cannabis industry, Global Health Clinics Ltd. manages medical facilities that provide guidance to patients seeking to legally obtain and use marijuana. The company is also involved in creating psilocybin products designated for s...

Global Health Clinics Financial Statement Overview

Summary

Financials are highly stressed: revenue is shrinking sharply (TTM down ~39%), gross profit is negative (costs exceed sales), and losses remain severe (TTM net margin around -43%). The balance sheet is a major risk with consistently negative equity and rising debt, and cash flow shows ongoing operating and free-cash-flow burn despite some moderation in TTM outflows.

Income Statement

7Very Negative

Balance Sheet

5Very Negative

Cash Flow

10Very Negative

Global Health Clinics Technical Analysis

Technical Analysis SentimentPositive
Last Price0.40

Price Trends

50DMA0.30Positive
100DMA0.34Positive
200DMA0.38Positive

Market Momentum

MACD0.02Positive
RSI67.43Neutral
STOCH0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MJRX.X, the sentiment is Positive. The current price of 0.40 is below the 20-day moving average (MA) of 0.40, above the 50-day MA of 0.30, and above the 200-day MA of 0.38, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 67.43 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:MJRX.X.

Global Health Clinics Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TSE:MJRX.X against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:GTIITSE:GTII72OutperformCAD 1.90B11.446.82%―3.81%344.13%
TSE:DHT.UNTSE:DHT.UN63NeutralCAD 997.22M-14.90-10.07%3.32%6.33%-1216.48%
TSE:CURATSE:CURA56NeutralCAD 3.12B-60.28-4.47%―1.50%81.84%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:VRNOTSE:VRNO51NeutralCAD 2.17B-1.66-28.93%―0.61%37.92%
TSE:MJRX.XTSE:MJRX.X43NeutralCAD 417.43K-0.2828.54%―-78.90%-9.28%

* Healthcare Sector Average

Performance Comparison

-50%0%50%TSE:MJRX.XTSE:CURATSE:GTIITSE:VRNOTSE:DHT.UNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
TSE:MJRX.X and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:MJRX.XGlobal Health Clinics Ltd.0.40-0.05-11.11%
TSE:CURACuraleaf Holdings (Otc)11.770.040.34%
TSE:GTIIGreen Thumb Industries (OTC)8.70-0.95-9.84%
TSE:VRNOVerano Holdings Corp.6.320.000.00%
TSE:DHT.UNDri Healthcare Plc Trust18.142.5216.15%

Global Health Clinics Corporate Events

Stock Split

Global Health Clinics Plans 9-for-1 Share Consolidation

Positive
Aug 13, 2026

Global Health Clinics Ltd. has announced plans to consolidate its share capital on a 9-for-1 basis, reducing its outstanding common shares from 9,392,113 to approximately 1,043,568, with fractional shares to be either rounded up or cancelled. The mov...

Business Operations and StrategyStock Split

Global Health Clinics Announces 10-for-1 Share Consolidation to Reshape Capital Structure

Neutral
Aug 13, 2026

Global Health Clinics Ltd. plans to consolidate its share capital on a 10-for-1 basis, reducing its outstanding common shares from 9,392,113 to approximately 1,043,568, with no fractional shares issued and small fractions cancelled or rounded up. The...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 24, 2026